Japan’s Omron targets 3 million blood pressure monitors annually at new Chennai plant by 2028
Japanese medical-device major Omron Healthcare has commenced full-scale production at its first manufacturing facility in India near Chennai, targeting an annual production capacity of three million blood pressure monitors by 2028.

The facility, located at Origins by Mahindra in Tamil Nadu, marks a significant expansion of the company’s manufacturing presence in India and is expected to strengthen domestic supplies while positioning Chennai as a potential global manufacturing hub.
According to the company, the approximately 24,000-square-metre plant has five production lines manufacturing blood pressure monitors for the Indian market. It currently produces three product series — HEM-7090, HEM-7181 and HEM-7183T — incorporating features such as blood pressure trend indicators, memory functions and Bluetooth connectivity.
Omron Healthcare President and CEO Ayumu Okada said India could become one of the company’s major manufacturing bases. The company is also looking to diversify production beyond Vietnam and strengthen its global supply chain.
The Chennai facility could eventually achieve an annual capacity of 3.5 million units with three-shift operations. The company is also considering expanding production to nebulisers, used in respiratory care, and supplying international markets, including Europe.
India presents a substantial opportunity for the company, with an estimated 300 million people living with hypertension. However, fewer than five per cent of households regularly use home blood pressure monitors.
Omron held approximately 40 per cent of India's home blood pressure monitor market in 2025. The company aims to increase awareness and adoption of home monitoring, while strengthening local sourcing and supporting the Centre's Make in India initiative. The factory is expected to employ around 120 people by November 2026.